JP2011174933A5 - - Google Patents

Download PDF

Info

Publication number
JP2011174933A5
JP2011174933A5 JP2011050083A JP2011050083A JP2011174933A5 JP 2011174933 A5 JP2011174933 A5 JP 2011174933A5 JP 2011050083 A JP2011050083 A JP 2011050083A JP 2011050083 A JP2011050083 A JP 2011050083A JP 2011174933 A5 JP2011174933 A5 JP 2011174933A5
Authority
JP
Japan
Prior art keywords
antibody
peptide
kit
urine
kit according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2011050083A
Other languages
English (en)
Japanese (ja)
Other versions
JP5570029B2 (ja
JP2011174933A (ja
Filing date
Publication date
Priority claimed from US10/388,930 external-priority patent/US20040180387A1/en
Application filed filed Critical
Publication of JP2011174933A publication Critical patent/JP2011174933A/ja
Publication of JP2011174933A5 publication Critical patent/JP2011174933A5/ja
Application granted granted Critical
Publication of JP5570029B2 publication Critical patent/JP5570029B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

JP2011050083A 2003-03-13 2011-03-08 卵巣癌査定のための尿のメソセリン/巨核球可能化因子関連ペプチド(mesothelin/megakaryocytepotentiatingfactorfamilypeptide)の検出 Expired - Lifetime JP5570029B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/388,930 US20040180387A1 (en) 2003-03-13 2003-03-13 Detection of urinary mesothelin-/megakaryocyte potentiating factor-related peptides for assessment of ovarian cancer
US10/388,930 2003-03-13

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2006507164A Division JP4722834B2 (ja) 2003-03-13 2004-03-15 卵巣癌査定のための尿のメソセリン/巨核球可能化因子関連ペプチド(mesothelin/megakaryocytepotentiatingfactorfamilypeptide)の検出

Publications (3)

Publication Number Publication Date
JP2011174933A JP2011174933A (ja) 2011-09-08
JP2011174933A5 true JP2011174933A5 (enExample) 2012-06-07
JP5570029B2 JP5570029B2 (ja) 2014-08-13

Family

ID=32962160

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2006507164A Expired - Lifetime JP4722834B2 (ja) 2003-03-13 2004-03-15 卵巣癌査定のための尿のメソセリン/巨核球可能化因子関連ペプチド(mesothelin/megakaryocytepotentiatingfactorfamilypeptide)の検出
JP2011050083A Expired - Lifetime JP5570029B2 (ja) 2003-03-13 2011-03-08 卵巣癌査定のための尿のメソセリン/巨核球可能化因子関連ペプチド(mesothelin/megakaryocytepotentiatingfactorfamilypeptide)の検出

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2006507164A Expired - Lifetime JP4722834B2 (ja) 2003-03-13 2004-03-15 卵巣癌査定のための尿のメソセリン/巨核球可能化因子関連ペプチド(mesothelin/megakaryocytepotentiatingfactorfamilypeptide)の検出

Country Status (4)

Country Link
US (1) US20040180387A1 (enExample)
EP (2) EP2316969B1 (enExample)
JP (2) JP4722834B2 (enExample)
WO (1) WO2004083449A2 (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005072341A2 (en) * 2004-01-21 2005-08-11 Fujirebio America, Inc. Detection of mesothelin-/megakaryocyte potentiating factor-related peptides in peritoneal fluid for assessment of the peritoneum and the peritoneal cavity
US20060014221A1 (en) * 2004-01-21 2006-01-19 Fujirebio Diagnostics, Inc. Detection of urinary mesothelin-/megakaryocyte potentiating factor-related peptides for assessment of mesothelioma
US20110003710A1 (en) * 2008-02-28 2011-01-06 John Hopkins University Selectin ligands useful in the diagnosis and treatment of cancer
JP2010014691A (ja) * 2008-06-20 2010-01-21 Igaku Seibutsugaku Kenkyusho:Kk 腹水中のメソテリン及び/又は巨核球増強因子を検出するための方法、キット、試薬及び装置
US20120115244A1 (en) 2010-11-09 2012-05-10 Abbott Laboratories Materials and methods for immunoassay of pterins
US8911732B2 (en) 2010-12-20 2014-12-16 Genentech, Inc. Anti-mesothelin antibodies and immunoconjugates
CN103344761A (zh) * 2013-04-23 2013-10-09 深圳市柏明胜医疗器械有限公司 一种he4量子点标记的双夹心免疫分析检测试剂盒及其应用
CN106716127B (zh) * 2014-10-02 2020-12-08 佐拉生物科学公司 用于检测卵巢癌的方法
CN106841190B (zh) * 2017-03-22 2020-07-24 西北师范大学 以TMB为显色剂的Ag+可视化检测方法

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
JPS6147500A (ja) 1984-08-15 1986-03-07 Res Dev Corp Of Japan キメラモノクロ−ナル抗体及びその製造法
EP0173494A3 (en) 1984-08-27 1987-11-25 The Board Of Trustees Of The Leland Stanford Junior University Chimeric receptors by dna splicing and expression
GB8422238D0 (en) 1984-09-03 1984-10-10 Neuberger M S Chimeric proteins
JPS61134325A (ja) 1984-12-04 1986-06-21 Teijin Ltd ハイブリツド抗体遺伝子の発現方法
EP0247091B1 (en) 1985-11-01 1993-09-29 Xoma Corporation Modular assembly of antibody genes, antibodies prepared thereby and use
US5139744A (en) * 1986-03-26 1992-08-18 Beckman Instruments, Inc. Automated laboratory work station having module identification means
US5225539A (en) * 1986-03-27 1993-07-06 Medical Research Council Recombinant altered antibodies and methods of making altered antibodies
DE768377T1 (de) 1988-09-02 1998-01-02 Dyax Corp Herstellung und Auswahl von Rekombinantproteinen mit verschiedenen Bindestellen
US5223409A (en) * 1988-09-02 1993-06-29 Protein Engineering Corp. Directed evolution of novel binding proteins
US5427908A (en) 1990-05-01 1995-06-27 Affymax Technologies N.V. Recombinant library screening methods
ES2139598T3 (es) 1990-07-10 2000-02-16 Medical Res Council Procedimientos para la produccion de miembros de parejas de union especifica.
GB9015198D0 (en) 1990-07-10 1990-08-29 Brien Caroline J O Binding substance
CA2093928C (en) * 1990-10-12 2000-02-29 Mark C. Willingham Monoclonal antibodies for detection and treatment of cancer
CA2095633C (en) 1990-12-03 2003-02-04 Lisa J. Garrard Enrichment method for variant proteins with altered binding properties
EP1279731B1 (en) 1991-03-01 2007-05-30 Dyax Corporation Process for the development of binding mini-proteins
DE69233367T2 (de) 1991-04-10 2005-05-25 The Scripps Research Institute, La Jolla Bibliotheken heterodimerer rezeptoren mittels phagemiden
DE4122599C2 (de) 1991-07-08 1993-11-11 Deutsches Krebsforsch Phagemid zum Screenen von Antikörpern
JP3328341B2 (ja) * 1991-12-27 2002-09-24 中外製薬株式会社 新規な巨核球増幅因子
US5622835A (en) * 1994-04-28 1997-04-22 The Wistar Institute Of Anatomy & Biology WT1 monoclonal antibodies
EP0871492B1 (en) * 1996-01-05 2003-11-26 THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by the Secretary, Department of Health and Human Services Mesothelium antigen and methods and kits for targeting it
CA2369433A1 (en) * 1999-02-26 2000-08-31 Pacific Northwest Research Institute Methods and compositions for diagnosing carcinomas
US6770445B1 (en) * 1999-02-26 2004-08-03 Pacific Northwest Research Institute Methods and compositions for diagnosing carcinomas
AU2002258518A1 (en) * 2001-03-14 2002-09-24 Millennium Pharmaceuticals, Inc. Nucleic acid molecules and proteins for the identification, assessment, prevention, and therapy of ovarian cancer

Similar Documents

Publication Publication Date Title
JP2011174933A5 (enExample)
JP5679818B2 (ja) 早期妊娠診断のための組成物および方法
JP2597013B2 (ja) 妊娠誘発高血圧および子かんのイムノアツセイおよび試薬
CN101523213B (zh) 天然形式人自分泌运动因子特异的抗体、其筛选方法、以及通过测定自分泌运动因子而检测恶性淋巴瘤的方法和检测试剂
JP2012509477A5 (enExample)
JP2006512891A5 (enExample)
CN101384903A (zh) 利用bcl-2水平的增高检测癌肿
EP2780468A2 (en) Detection, isolation and analysis of rare cells in biological fluids
AU2009339802B2 (en) RBM3 as a marker for malignant melanoma prognosis
JP2011507810A5 (enExample)
JP2023156347A (ja) 胎児細胞を単離、検出及び解析する組成物及び方法
CN103197076A (zh) 用于诊断癌症的生物标志物以及使用该生物标志物分离癌细胞的方法
CN108738347B (zh) 辅助肝细胞癌患者的再发风险预测的方法、装置、计算机程序制品及试剂盒
JP6880046B2 (ja) Ciz1 b変異体を検出するためのフィブリノゲン捕捉剤の使用
TWI504897B (zh) 硫酸吲哚酚之測定方法
KR101341732B1 (ko) 난소암 진단을 위한 콜라겐 유형 ⅵ 알파 1의 신규한 용도
JP2017526895A (ja) メラトニンの高感度検出
US11199539B2 (en) Methods, compositions and devices for improving the sensitivity of assays
US20180246121A1 (en) Immunological test method and immunological test kit
KR20240161980A (ko) 갑상선암의 진단을 위한 신규한 바이오 마커
WO2024100036A1 (en) Improved method for the screening, diagnosis or monitoring of endometriosis, kit and uses thereof
JP2008537101A (ja) 薬物応答を予測するための前立腺特異的抗原の使用
WO2006090146A1 (en) Assay
CN120677381A (zh) 检测细胞膜蛋白质的方法
WO2010092077A1 (en) Galectin-1 (gal1) as a biomarker for differential diagnosis of osteosarcoma and chondrosarcoma